car t cells for autoimmune disease
7% Faster Recovery - Beginner's Secret To Chronic Disease Management
Look, here's the thing: CD19 CAR-T therapy is delivering remission for refractory autoimmune disease, cutting drug load and hospital stays, and could become a cornerstone of chronic disease management in Australia. The early data suggest a shift from lifelong immunosuppression to targeted, durable control. Medical Disclaimer: This article